Home›Trial›NCT06095115

🔬NCT06095115Phase 3ACTIVE NOT RECRUITING

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Study Summary

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Conditions

Plaque Psoriasis

Interventions / Drugs

JNJ-77242113 Placebo

View on ClinicalTrials.gov ↗

Sponsor

Johnson & Johnson

Diversified Pharma

Study Details

Enrollment684 participants

Primary Completion—

Lead SponsorJanssen Research & Development, LLC

Data Retrieved2026-04-11 02:55:31.549895+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.